Initial Experience of Clinical Use of [^99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study

Numerous different molecules of prostate-specific membrane antigen (PSMA) ligands are used to detect prostate cancer (PCa); most approaches utilize gallium PET and a few reports describe the role of SPECT/CT. [^99mTc]Tc-PSMA-T4 is a new radiopharmaceutical designed for the diagnosis of pat...

詳細記述

書誌詳細

主要な著者:	Jarosław B. Ćwikła, Marek Roslan, Iwona Skoneczna, Monika Kempińska-Wróbel, Michał Maurin, Wojciech Rogowski, Barbara Janota, Anna Szarowicz, Piotr Garnuszek
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-10-01
シリーズ:	Pharmaceuticals
主題:	prostate cancer molecular imaging prostate specific membrane antigen (PSMA) [<sup>99m</sup>Tc]Tc-PSMA-T4
オンライン･アクセス:	https://www.mdpi.com/1424-8247/14/11/1107
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!